Stirlingshire Investments’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Stirlingshire Investments's LMAT Position: Q2 2026 in Review
Stirlingshire Investments sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 1,900 shares — an estimated $207K sold.
Stirlingshire Investments first reported a position in LMAT in Q1 2026 and held it in 1 quarter. The position peaked at $207K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Stirlingshire Investments reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
- Stirlingshire Investments sold 1,900 LeMaitre Vascular shares in Q2 2026, an estimated $207K.
- Stirlingshire Investments first reported a position in LeMaitre Vascular in Q1 2026 and held it in 1 quarter.
- Stirlingshire Investments's LeMaitre Vascular position peaked at $207K in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Stirlingshire Investments's 13F filing for Q2 2026, filed 31 Jul 2026.